Mycophenolate mofetil in primary Sjögren's syndrome: A treatment option for agranulocytosis

Revista Brasileira de Reumatologia

Volumn 52, Issue 2, 2012, Pages 295-299

  Fialho, Sonia Cristina de Magalhães Souza ^a   Bergamaschi, Samue ^b   Neves, Fabrício Souza ^a   Zimmermann, Adriana Fontes ^b   de Castro, Gláucio Ricardo Werner ^b   Pereira, Ivânio Alves ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Agranulocytosis; Immunosuppressive agents; Neutropenia; Sj gren's syndrome; Treatment outcome

Indexed keywords

C REACTIVE PROTEIN; CEFTAZIDIME; CORTICOSTEROID; CREATININE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RHEUMATOID FACTOR; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

AGED; AGRANULOCYTOSIS; ANTIBODY DETECTION; ARTICLE; BLOOD EXAMINATION; BONE MARROW BIOPSY; CASE REPORT; CHRONIC DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CORNEA ULCER; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; EYE EXAMINATION; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOPHENOTYPING; KERATOCONJUNCTIVITIS SICCA; PROTEIN BLOOD LEVEL; PROTEIN ELECTROPHORESIS; SJOEGREN SYNDROME; XEROPHTHALMIA; XEROSTOMIA;

AGED; AGRANULOCYTOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; SJOGREN'S SYNDROME;

EID: 84859396937     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Fox RI, Howell FV, Bone RC, Michelson P. Primary Sjögren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum 1984; 14(2):77-105.
2. Starkebaum G, Dancey JT, Arend WP. Chronic neutropenia: possible association with Sjögren's syndrome. J Rheumatol 1981; 8(4):679-684.
3. Petrasovicová V, Pavelka K Jr, Neuwirtová R, Korinková P, Alusík S, Trnavský K. Agranulocytosis in a patient with primary Sjögren's syndrome. Clin Rheumatol 1990; 9(4):530-534.
4. Ramakrishna R, Chaudhuri K, Sturgess A, Manoharan A. Haematological manifestations of primary Sjögren's syndrome: a clinicopathological study. Q J Med 1992; 83(303):547-554.
5. Yamato E, Fujioka Y, Masugi F, Nakamaru M, Tahara Y, Murata Y et al. Autoimmune neutropenia with anti-neutrophil autoantibody associated with Sjögren's syndrome. Am J Med Sci 1990; 300(2):102-103.
6. Coppo P, Sibilia J, Maloisel F, Schlageter MH, Voyer AL, Gouilleux-Gruart V et al. Primary Sjögren's syndrome associated agranulocytosis: a benign disorder? Ann Rheum Dis 2003; 62(5):476-478.
7. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000; 47(2/3):85-118.
8. Hansen A, Lipsky PE, Dörner T. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007; 9(4):218.
9. Ahmadi-Simab K, Lamprecht P, Nölle B, Ai M, Gross WL. Successful treatment of refractory anterior scleritis in primary Sjögren's syndrome with rituximab. Ann Rheum Dis 2005; 64(7):1087-1088.
10. Willeke P, Domschke W, Gaubitz M. Mycophenolate Mofetil for the treatment of primary Sjögren's syndrome: a case report. Ann Rheum Dis 2003; 62(Suppl 1):352.